These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 2243145)

  • 1. L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat.
    Crofford LJ; Rader JI; Dalakas MC; Hill RH; Page SW; Needham LL; Brady LS; Heyes MP; Wilder RL; Gold PW
    J Clin Invest; 1990 Nov; 86(5):1757-63. PubMed ID: 2243145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological and immunological effects of ingesting L-tryptophan and 1,1'-ethylidenebis (L-tryptophan) in Lewis rats.
    Love LA; Rader JI; Crofford LJ; Raybourne RB; Principato MA; Page SW; Trucksess MW; Smith MJ; Dugan EM; Turner ML
    J Clin Invest; 1993 Mar; 91(3):804-11. PubMed ID: 8450062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental pathology. Mast cell and eosinophil infiltration in intestinal mucosa of Lewis rats treated with L-tryptophan implicated in human eosinophilia myalgia syndrome.
    DeSchryver-Kecskemeti K; Gramlich TL; Crofford LJ; Rader JI; Page SW; Needham LL; Hill RH; Sternberg EM
    Mod Pathol; 1991 May; 4(3):354-7. PubMed ID: 2068062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,1'-Ethylidenebis[L-tryptophan], a contaminant implicated in L-tryptophan eosinophilia myalgia syndrome, suppresses mRNA expression of hypothalamic corticotropin-releasing hormone in Lewis (LEW/N) rat brain.
    Brady LS; Page SW; Thomas FS; Rader JL; Lynn AB; Misiewicz-Poltorak B; Zelazowski E; Crofford LJ; Zelazowski P; Smith C
    Neuroimmunomodulation; 1994 Jan; 1(1):59-65. PubMed ID: 8528886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A decomposition product of a contaminant implicated in L-tryptophan eosinophilia myalgia syndrome affects spinal cord neuronal cell death and survival through stereospecific, maturation and partly interleukin-1-dependent mechanisms.
    Brenneman DE; Page SW; Schultzberg M; Thomas FS; Zelazowski P; Burnet P; Avidor R; Sternberg EM
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1029-35. PubMed ID: 8355179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ["Eosinophilia-myalgia" syndrome due to L-tryptophan containing products. Cooperative evaluation of French Regional Centers of Pharmacovigilance. Analysis of 24 cases].
    Castot A; Bidault I; Bournerias I; Carlier P; Efthymiou ML
    Therapie; 1991; 46(5):355-65. PubMed ID: 1754978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan.
    Silver RM; Heyes MP; Maize JC; Quearry B; Vionnet-Fuasset M; Sternberg EM
    N Engl J Med; 1990 Mar; 322(13):874-81. PubMed ID: 1690352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophilia-myalgia syndrome associated with L-tryptophan use.
    Montanaro A; Wakefield D
    Med J Aust; 1990 Oct; 153(8):491-3. PubMed ID: 2215340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A murine model of the eosinophilia-myalgia syndrome induced by 1,1'-ethylidenebis (L-tryptophan).
    Silver RM; Ludwicka A; Hampton M; Ohba T; Bingel SA; Smith T; Harley RA; Maize J; Heyes MP
    J Clin Invest; 1994 Apr; 93(4):1473-80. PubMed ID: 8163652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic fasciitis associated with tryptophan ingestion. A manifestation of eosinophilia-myalgia syndrome.
    Gordon ML; Lebwohl MG; Phelps RG; Cohen SR; Fleischmajer R
    Arch Dermatol; 1991 Feb; 127(2):217-20. PubMed ID: 1990986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiologic studies of the association of L-tryptophan with the eosinophilia-myalgia syndrome: a critique.
    Shapiro S
    J Rheumatol Suppl; 1996 Oct; 46():44-58; discussion 58-9. PubMed ID: 8895181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophilic fasciitis is clinically distinguishable from the eosinophilia-myalgia syndrome and is not associated with L-tryptophan use.
    Varga J; Griffin R; Newman JH; Jimenez SA
    J Rheumatol; 1991 Feb; 18(2):259-63. PubMed ID: 2023221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic and L-tryptophan-associated eosinophilic fasciitis before and after L-tryptophan contamination.
    Blauvelt A; Falanga V
    Arch Dermatol; 1991 Aug; 127(8):1159-66. PubMed ID: 1863073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [L-tryptophan-induced eosinophilia-myalgia syndrome with features of diffuse fasciitis with eosinophilia].
    Senff H; Köllner A; Engelmann L; Woort-Menker M; Mensing H; Kunze J
    Hautarzt; 1990 Oct; 41(10):578-82. PubMed ID: 2258302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-tryptophan associated eosinophilia-myalgia syndrome.
    Katz JD; Wakem CJ; Parke AL
    J Rheumatol; 1990 Nov; 17(11):1559-61. PubMed ID: 2273504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophilia-myalgia syndrome in Wisconsin.
    Butler JC; Davis JP
    Wis Med J; 1990 Dec; 89(12):687-91. PubMed ID: 2293489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [L-tryptophan and the eosinophilia-myalgia syndrome--consequences for artificial nutrition?].
    Bässler KH
    Infusionstherapie; 1991 Feb; 18(1):5-10. PubMed ID: 1903129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tryptophan-induced eosinophilia-myalgia syndrome.
    Criswell LA; Sack KE
    West J Med; 1990 Sep; 153(3):269-74. PubMed ID: 2219890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An eosinophilia-myalgia syndrome associated with an L-tryptophan containing product.
    Saag KG; Goldschmidt R; Vernof H; Golbus J
    J Rheumatol; 1990 Nov; 17(11):1551-3. PubMed ID: 2273501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A contaminant of L-tryptophan enhances expression of dermal collagen in a murine model of eosinophilia myalgia syndrome.
    Suzuki S; Tourkina E; Ludwicka A; Hampton M; Bolster M; Maize J; Silver R
    Proc Assoc Am Physicians; 1996 Jul; 108(4):315-22. PubMed ID: 8863345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.